UY35899A - NEW USE OF ACLIDINIO - Google Patents

NEW USE OF ACLIDINIO

Info

Publication number
UY35899A
UY35899A UY0001035899A UY35899A UY35899A UY 35899 A UY35899 A UY 35899A UY 0001035899 A UY0001035899 A UY 0001035899A UY 35899 A UY35899 A UY 35899A UY 35899 A UY35899 A UY 35899A
Authority
UY
Uruguay
Prior art keywords
aclidinio
new use
stereoisomers
cough
solvate
Prior art date
Application number
UY0001035899A
Other languages
Spanish (es)
Inventor
Garcia Gil Maria Esther
Jarreta Fernandez Diana
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of UY35899A publication Critical patent/UY35899A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona aclidinio o cualquiera de sus estereoisómeros o mezcla de estereoisómeros, o una sal farmacéuticamente aceptable o solvato del mismo, para el tratamiento de la tos.The present invention provides aclidinium or any of its stereoisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for the treatment of cough.

UY0001035899A 2013-12-19 2014-12-19 NEW USE OF ACLIDINIO UY35899A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13382532 2013-12-19

Publications (1)

Publication Number Publication Date
UY35899A true UY35899A (en) 2015-07-31

Family

ID=49886822

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035899A UY35899A (en) 2013-12-19 2014-12-19 NEW USE OF ACLIDINIO

Country Status (4)

Country Link
AR (1) AR098866A1 (en)
TW (1) TW201605440A (en)
UY (1) UY35899A (en)
WO (1) WO2015091288A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1824466A4 (en) * 2004-12-16 2008-03-05 Advanced Inhalation Res Inc Compositions and methods for pulmonary conditions
EP2100598A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) * 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Also Published As

Publication number Publication date
AR098866A1 (en) 2016-06-22
TW201605440A (en) 2016-02-16
WO2015091288A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
CL2018000978A1 (en) Peptide macrocycles against acinetobacter baumannii
EA201692203A1 (en) TANK-BINDING KINAZ INHIBITING COMPOUNDS
ES2796903T8 (en) Procedure for the use of anti-CD79b immunoconjugates
ECSP17018120A (en) TRIAZOLOPYRAZINONES AS PDE1 INHIBITORS
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
CL2017001661A1 (en) Fused bicyclic compounds for the treatment of a disease.
DOP2017000178A (en) BACE1 SELECTIVE INHIBITORS
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
GEP20217240B (en) Pharmaceutical composition
PL3105186T3 (en) Device for dispersing foul gaseous effluent emissions at the source
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
DK3215223T3 (en) BUPRENORPHIN DOSAGE SCHEMES
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
UY36117A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS DISEASES.
GT201300249A (en) ACLIDINIO FOR USE IN THE IMPROVEMENT OF SLEEP QUALITY IN RESPIRATORY PATIENTS
BR112017013286A2 (en) isoxazoline compound, and use of an isoxazoline compound.
EA201791099A1 (en) QUINOLIN CARBOXAMIDE FOR USE IN THE TREATMENT OF LEUKEMIA
CL2016003095A1 (en) Peptides as oxytocin agonists
ECSP16071574A (en) HEXAHYDROFUROPYRROLS AS PDE1 INHIBITORS
UY35196A (en) NEW USE OF ACLIDINIO
DOP2016000325A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
EP3125876B8 (en) New use of n,n-bis-2-mercaptoethyl isophthalamide
UY35899A (en) NEW USE OF ACLIDINIO
IL264538B (en) New use of n,n-bis-2-mercaptoethyl isophthalamide

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20201204